Table 2 Hazard of subsequent all-cause and cause-specific late mortality after BMT by pre-frailty status.

From: Pre-frailty after blood or marrow transplantation and the risk of subsequent mortality

 

Unadjusted HR (95% CI)

Adjusted a HR (95% CI)

All-cause mortality

Non-recurrence-related mortality

Recurrence-related mortality

All-cause mortality

Non-recurrence-related mortality

Recurrence-related mortality

Pre-frailty statusa

     Non-frail

Reference

Reference

Reference

Reference

Reference

Reference

     Pre-frail

1.9 (1.6–2.3)

1.9 (1.4–2.4)

1.9 (1.3–2.5)

1.6 (1.4–2.0)

1.6 (1.2–2.1)

1.4 (1.0–1.9)

  1. Bold indicates statistically significant differences between groups.
  2. BMT blood or marrow transplantation, cGvHD Chronic Graft vs Host Disease, TBI Total Body irradiation, HR hazard ratio, CI confidence intervals.
  3. aAdjusted for age at completing the survey, time from BMT to completing the survey, sex, race/ethnicity, health insurance, socioeconomic status, primary diagnosis, risk of relapse at BMT, BMT type/cGvHD, stem cell source, condition intensity/TBI, post-BMT relapse, pre-BMT radiation, chronic health conditions, smoking, lack of exercise, alcohol consumption and BMT institution.
Back to article page